Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4416)
All Articles published online
|
Publishing Process of This Article
|
Jul 27, 2022 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liakina V, Strainiene S, Stundiene I, Maksimaityte V, Kazenaite E. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis. World J Hepatol 2022; 14(7): 1277-1290 [PMID: 36158907 DOI: 10.4254/wjh.v14.i7.1277] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i7/1277.htm |
| Number | Citing Articles |
| 1 |
Marica Meroni, Miriam Longo, Paola Dongiovanni. Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1411706
|
| 2 |
Takahiro Kodama, Tetsuo Takehara. Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma. Seminars in Liver Disease 2024; 44(02): 147 doi: 10.1055/a-2289-2298
|
| 3 |
Shehzeen Noor, Shaukat Ali, Shumaila Riaz, Iqra Sardar, Muhammad Adeel Farooq, Ayesha Sajjad. Chemopreventive role of probiotics against cancer: a comprehensive mechanistic review. Molecular Biology Reports 2023; 50(1): 799 doi: 10.1007/s11033-022-08023-7
|
| 4 |
Yangie Dwi Pinanga, Kyung-hee Pyo, Eun-Ae Shin, Haesong Lee, Eun Hae Lee, Wonsik Kim, Soyeon Kim, Ji Eon Kim, Semi Kim, Jung Weon Lee. Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development. Life Sciences 2024; 358: 123164 doi: 10.1016/j.lfs.2024.123164
|